PMC:7326463 / 3010-3295 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T34","span":{"begin":80,"end":90},"obj":"Disease"},{"id":"T35","span":{"begin":105,"end":113},"obj":"Disease"}],"attributes":[{"id":"A34","pred":"mondo_id","subj":"T34","obj":"http://purl.obolibrary.org/obo/MONDO_0016426"},{"id":"A35","pred":"mondo_id","subj":"T35","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Fig. 1 Timeline for an immunocompetent patient who developed invasive pulmonary fusariosis during severe COVID-19. Day 1 is the day the patient was admitted to the intensive care unit. D, days; BAL, bronchoalveolar lavage; GM, galactomannan index determination; BDG, β-D-glucan dosage."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T13","span":{"begin":194,"end":197},"obj":"Chemical"},{"id":"T14","span":{"begin":223,"end":225},"obj":"Chemical"},{"id":"T15","span":{"begin":227,"end":240},"obj":"Chemical"},{"id":"T16","span":{"begin":271,"end":277},"obj":"Chemical"}],"attributes":[{"id":"A13","pred":"chebi_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/CHEBI_64198"},{"id":"A14","pred":"chebi_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/CHEBI_74120"},{"id":"A15","pred":"chebi_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/CHEBI_27680"},{"id":"A16","pred":"chebi_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/CHEBI_37163"}],"text":"Fig. 1 Timeline for an immunocompetent patient who developed invasive pulmonary fusariosis during severe COVID-19. Day 1 is the day the patient was admitted to the intensive care unit. D, days; BAL, bronchoalveolar lavage; GM, galactomannan index determination; BDG, β-D-glucan dosage."}

{"project":"LitCovid-PD-GlycoEpitope","denotations":[{"id":"T2","span":{"begin":227,"end":240},"obj":"GlycoEpitope"}],"attributes":[{"id":"A2","pred":"glyco_epitope_db_id","subj":"T2","obj":"http://www.glycoepitope.jp/epitopes/EP0510"}],"text":"Fig. 1 Timeline for an immunocompetent patient who developed invasive pulmonary fusariosis during severe COVID-19. Day 1 is the day the patient was admitted to the intensive care unit. D, days; BAL, bronchoalveolar lavage; GM, galactomannan index determination; BDG, β-D-glucan dosage."}

{"project":"LitCovid-PubTator","denotations":[{"id":"70","span":{"begin":39,"end":46},"obj":"Species"},{"id":"71","span":{"begin":136,"end":143},"obj":"Species"},{"id":"72","span":{"begin":223,"end":225},"obj":"Chemical"},{"id":"73","span":{"begin":227,"end":240},"obj":"Chemical"},{"id":"74","span":{"begin":262,"end":265},"obj":"Chemical"},{"id":"75","span":{"begin":267,"end":277},"obj":"Chemical"},{"id":"76","span":{"begin":61,"end":90},"obj":"Disease"},{"id":"77","span":{"begin":105,"end":113},"obj":"Disease"}],"attributes":[{"id":"A70","pred":"tao:has_database_id","subj":"70","obj":"Tax:9606"},{"id":"A71","pred":"tao:has_database_id","subj":"71","obj":"Tax:9606"},{"id":"A72","pred":"tao:has_database_id","subj":"72","obj":"MESH:D005839"},{"id":"A73","pred":"tao:has_database_id","subj":"73","obj":"MESH:C012990"},{"id":"A76","pred":"tao:has_database_id","subj":"76","obj":"MESH:D060585"},{"id":"A77","pred":"tao:has_database_id","subj":"77","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Fig. 1 Timeline for an immunocompetent patient who developed invasive pulmonary fusariosis during severe COVID-19. Day 1 is the day the patient was admitted to the intensive care unit. D, days; BAL, bronchoalveolar lavage; GM, galactomannan index determination; BDG, β-D-glucan dosage."}

{"project":"LitCovid-sentences","denotations":[{"id":"T24","span":{"begin":0,"end":114},"obj":"Sentence"},{"id":"T25","span":{"begin":115,"end":184},"obj":"Sentence"},{"id":"T26","span":{"begin":185,"end":285},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Fig. 1 Timeline for an immunocompetent patient who developed invasive pulmonary fusariosis during severe COVID-19. Day 1 is the day the patient was admitted to the intensive care unit. D, days; BAL, bronchoalveolar lavage; GM, galactomannan index determination; BDG, β-D-glucan dosage."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T45","span":{"begin":70,"end":79},"obj":"UBERON:0002048"},{"id":"T46","span":{"begin":105,"end":113},"obj":"SP_7"},{"id":"T47","span":{"begin":174,"end":183},"obj":"UBERON:0007221"},{"id":"T48","span":{"begin":199,"end":214},"obj":"UBERON:0002186"},{"id":"T49","span":{"begin":227,"end":240},"obj":"CHEBI:27680;CHEBI:27680"},{"id":"T50","span":{"begin":271,"end":277},"obj":"CHEBI:28793;CHEBI:28793"},{"id":"T13465","span":{"begin":70,"end":79},"obj":"UBERON:0002048"},{"id":"T81946","span":{"begin":105,"end":113},"obj":"SP_7"},{"id":"T88494","span":{"begin":174,"end":183},"obj":"UBERON:0007221"},{"id":"T46519","span":{"begin":199,"end":214},"obj":"UBERON:0002186"},{"id":"T16525","span":{"begin":227,"end":240},"obj":"CHEBI:27680;CHEBI:27680"},{"id":"T97325","span":{"begin":271,"end":277},"obj":"CHEBI:28793;CHEBI:28793"},{"id":"T53","span":{"begin":174,"end":183},"obj":"UBERON:0007221"},{"id":"T54","span":{"begin":199,"end":214},"obj":"UBERON:0002186"},{"id":"T55","span":{"begin":227,"end":240},"obj":"CHEBI:27680;CHEBI:27680"},{"id":"T56","span":{"begin":271,"end":277},"obj":"CHEBI:28793;CHEBI:28793"}],"text":"Fig. 1 Timeline for an immunocompetent patient who developed invasive pulmonary fusariosis during severe COVID-19. Day 1 is the day the patient was admitted to the intensive care unit. D, days; BAL, bronchoalveolar lavage; GM, galactomannan index determination; BDG, β-D-glucan dosage."}